BioCentury
ARTICLE | Company News

Portola, Aciex in ophthalmic deal

February 28, 2013 2:08 AM UTC

Portola Pharmaceuticals Inc. (South San Francisco, Calif.) granted Aciex Therapeutics Inc. (Westborough, Mass.) exclusive rights to co-develop Portola's portfolio of small molecule dual spleen tyrosin...